$ICPT News Drug companies Salix, Intercept ree
Post# of 74540
Posted On: 11/16/2014 1:53:45 PM
$ICPT News
Drug companies Salix, Intercept reeling after earnings, drama 12:15 p.m. Nov. 7, 2014 - Russ Britt
10 Nasdaq stocks with returns of at least 240% in 2014 4:38 p.m. Sept. 11, 2014 - Philip van Doorn
U.S. stocks end lower; Dow turns negative for the year 3:06 p.m. Aug. 12, 2014 - Anora Mahmudova
Skullcandy gains on upgrade,Tesla reverses gains 1:37 p.m. Aug. 12, 2014 - Sue Chang
Two drug makers diverge in Wall Street woods, and see huge moves 10:31 a.m. Aug. 12, 2014 - Russ Britt
Intercept shares surge after releasing positive liver drug data 7:04 a.m. Aug. 12, 2014 - Peter Loftus
Biotech hammered as ETFs down 5%, while some stocks fall 10% 12:55 p.m. April 10, 2014 - Russ Britt
Is biotech caught in a bubble, and is it popping? 12:13 p.m. April 8, 2014 - Russ Britt
Intercept investors see glass half empty as stock falls on drug news 3:32 p.m. March 17, 2014 - Russ Britt
This shocking strategy will save your portfolio 6:01 a.m. Jan. 15, 2014 - Jeff Reeves
Alnylam shares settle down after 40% gain; analysts are skeptical 1:16 p.m. Jan. 14, 2014 - Russ Britt
Intercept, Intuitive take diverging paths on the market roller coaster 10:51 a.m. Jan. 14, 2014 - Russ Britt
Dow industrials suffer worst drop since Sept. 20: Stock market live blog recap 4:41 p.m. Jan. 13, 2014 - blogs.marketwatch.com
Beam up on Suntory deal; Elliott report lifts Juniper 4:18 p.m. Jan. 13, 2014 - Sue Chang
Merck shares hit 52-week high on drug hopes, plans for cutbacks 12:31 p.m. Jan. 13, 2014 - Russ Britt
Intercept, Lululemon, SodaStream shares slump 10:22 a.m. Jan. 13, 2014 - Saumya Vaishampayan
S&P 500 gains for week; builder stocks rally as yields fall; the wonder of liver-drug stocks (live blog recap) 10:15 a.m. Jan. 13, 2014 - blogs.marketwatch.com
Clovis Oncology, seen as 'next ICPT,' jumps 5% 9:47 a.m. Jan. 13, 2014 - Victor Reklaitis
Intercept shares trip short-sale circuit breaker 9:32 a.m. Jan. 13, 2014 - Laura Mandaro
Intercept, Celgene on move amid J.P. Morgan event 9:20 a.m. Jan. 13, 2014 - Victor Reklaitis
Biotech Stock Mailbag: Spectrum, Intercept, Orexigen, Amarin, MannKind 6:00 a.m. Nov. 14, 2014 - TheStreet.com
Intercept Pharmaceuticals Slumps: ICPT Falls 5.9% in Session - Tale of the Tape 8:34 a.m. Nov. 13, 2014 - Zacks.com
Intercept Pharmaceuticals (ICPT) Is Weak On High Volume Today 10:00 a.m. Nov. 12, 2014 - TheStreet.com
Intercept Pharmaceuticals (ICPT) Downgraded From Hold to Sell 9:21 a.m. Nov. 12, 2014 - TheStreet.com
Intercept Pharmaceuticals' (ICPT) AASLD Investor Event - Transcript 1:54 p.m. Nov. 11, 2014 - Seeking Alpha
Conatus Pharmaceuticals (CNAT): Will Loss Narrow in Q3? - Analyst Blog 1:50 p.m. Nov. 11, 2014 - Zacks.com
Intercept Pharmaceuticals' Shares Crash on FLINT Results - Analyst Blog 5:03 p.m. Nov. 10, 2014 - Zacks.com
Intercept Seen as Poster-boy for Possible Biotech Bubble 2:58 p.m. Nov. 10, 2014 - TheStreet.com
Biotech Weekly: When Mid Caps Are Priced Nearly For Perfection 10:28 a.m. Nov. 10, 2014 - Seeking Alpha
Intercept Pharmaceuticals (ICPT) Marked As A Dead Cat Bounce Stock 9:48 a.m. Nov. 10, 2014 - TheStreet.com
Stock Movers: Why Medicals Issues Are Dipping Today 2:26 p.m. Nov. 7, 2014 - Investors Business Daily
Intercept Pharmaceuticals (ICPT) Trading With Heavy Volume Before Market Open 8:34 a.m. Nov. 7, 2014 - TheStreet.com
10-Q: INTERCEPT PHARMACEUTICALS INC 5:24 p.m. Nov. 6, 2014 - Edgar Online - (EDG = 10Q, 10K)
Will Intercept Pharmaceuticals' (ICPT) Q3 Loss Narrow? - Analyst Blog 4:02 p.m. Nov. 6, 2014 - Zacks.com
Meet The 5 Companies Loving Obamacare 7:04 p.m. Nov. 4, 2014 - Benzinga.com
The Time Is Now For Northwest Biotherapeutics 3:16 p.m. Oct. 29, 2014 - Seeking Alpha
3 Hot Ways to Play the Biotechnology Bonanza 6:36 a.m. Sept. 16, 2014 - InvestorPlace.com
Biotech Stocks With Upside Target Ebola, Liver Disease 6:30 a.m. Sept. 16, 2014 - InvestorPlace.com
Is Intercept Pharmaceuticals Building The Next Great Specialty Franchise? 2:30 p.m. Sept. 15, 2014 - Seeking Alpha
Biotechs With Upside Target Ebola And Liver Disease: MLV's Vernon Bernardino 9:16 a.m. Sept. 11, 2014 - Seeking Alpha
Intercept Announces Additional Data for OCA in Primary Biliary Cirrhosis 8:02 a.m. Nov. 8, 2014 - GlobeNewswire
FLINT Trial in NASH Published in The Lancet 7:06 p.m. Nov. 6, 2014 - GlobeNewswire
Intercept to Report Third Quarter 2014 Results on November 7 and Present at Upcoming Conferences 5:02 a.m. Oct. 31, 2014 - GlobeNewswire
Recognition, Product Enhancement, Marketing Approval, Upcoming Events, and Quarterly Earnings - Research Reports on Abbott, Illumina, Thermo Fisher, Intercept and Stryker 7:40 a.m. Oct. 22, 2014 - PR Newswire - PRF
Critical Alerts For Exxon Mobil, Celgene, Verizon, Intercept Pharmaceuticals and Lockheed Martin Released By InvestorsObserver 8:31 a.m. Oct. 8, 2014 - PR Newswire - PRF
Intercept Announces Data to be Presented at the 2014 AASLD Annual Meeting 5:30 a.m. Oct. 8, 2014 - GlobeNewswire
Quarterly Changes to the NASDAQ Q-50 Index 6:06 a.m. Sept. 15, 2014 - GlobeNewswire
Intercept Pharmaceuticals Recognizes International PBC Day 5:56 a.m. Sept. 12, 2014 - GlobeNewswire
Critical Alerts For Apple, Kinder Morgan, Stratasys, Intercept Pharmaceuticals and NPS Pharmaceuticals Released By InvestorsObserver 8:31 a.m. Sept. 8, 2014 - PR Newswire - PRF
Intercept to Present at Upcoming Investor Conferences 7:05 a.m. Aug. 26, 2014 - GlobeNewswire
Drug Approvals, Financial Results, Market Activity, New Mobile Applications, and Company Updates - Research Reports on Intercept, Exact Sciences, Thermo Fisher Scientific, Illumina and Agilent 8:00 a.m. Aug. 15, 2014 - PR Newswire - PRF
Critical Alerts For GoPro, Intercept Pharmaceuticals, Pixelworks, Vertex Pharmaceuticals and General Mills. Released By InvestorsObserver 8:31 a.m. Aug. 13, 2014 - PR Newswire - PRF
Intercept to Host Second Quarter 2014 Update on August 11 and Present at Upcoming Investor Conference 4:01 p.m. Aug. 4, 2014 - GlobeNewswire
Galectin, Intercept, Others Vying for Lead Drugs in NASH Epidemic 9:03 a.m. July 24, 2014 - ACCESSWIRE
Intercept Pharmaceuticals Names Lazar Partners Agency of Record 9:08 a.m. July 10, 2014 - Marketwire
Catalysts on the Horizon for Companies Developing NAFLD and NASH Drugs 8:42 a.m. June 26, 2014 - ACCESSWIRE
Conference Presentations, Settlement and License Agreement, New Leadership, and Start of Phase III Study - Analyst Notes on Alexion, Mylan, Novartis, GSK and Intercept 4:50 a.m. June 11, 2014 - PR Newswire - PRF
FDA Approvals, Digital Health Guidance, Conference Presentations, and Recognitions - Analyst Notes on Intercept Pharmaceuticals, Cigna, Baxter, Questcor and Mallinckrodt 6:00 a.m. June 3, 2014 - PR Newswire - PRF
Technical Coverage of Health Care Sector Equities -- Research on Intercept Pharma, ACADIA Pharma, DENTSPLY Intl., and OraSure Technologies 10:42 a.m. May 15, 2014 - PR Newswire - PRF
Wall Street In and Out of Love with NASH Drug Developers 9:21 a.m. May 13, 2014 - ACCESSWIRE
Drug companies Salix, Intercept reeling after earnings, drama 12:15 p.m. Nov. 7, 2014 - Russ Britt
10 Nasdaq stocks with returns of at least 240% in 2014 4:38 p.m. Sept. 11, 2014 - Philip van Doorn
U.S. stocks end lower; Dow turns negative for the year 3:06 p.m. Aug. 12, 2014 - Anora Mahmudova
Skullcandy gains on upgrade,Tesla reverses gains 1:37 p.m. Aug. 12, 2014 - Sue Chang
Two drug makers diverge in Wall Street woods, and see huge moves 10:31 a.m. Aug. 12, 2014 - Russ Britt
Intercept shares surge after releasing positive liver drug data 7:04 a.m. Aug. 12, 2014 - Peter Loftus
Biotech hammered as ETFs down 5%, while some stocks fall 10% 12:55 p.m. April 10, 2014 - Russ Britt
Is biotech caught in a bubble, and is it popping? 12:13 p.m. April 8, 2014 - Russ Britt
Intercept investors see glass half empty as stock falls on drug news 3:32 p.m. March 17, 2014 - Russ Britt
This shocking strategy will save your portfolio 6:01 a.m. Jan. 15, 2014 - Jeff Reeves
Alnylam shares settle down after 40% gain; analysts are skeptical 1:16 p.m. Jan. 14, 2014 - Russ Britt
Intercept, Intuitive take diverging paths on the market roller coaster 10:51 a.m. Jan. 14, 2014 - Russ Britt
Dow industrials suffer worst drop since Sept. 20: Stock market live blog recap 4:41 p.m. Jan. 13, 2014 - blogs.marketwatch.com
Beam up on Suntory deal; Elliott report lifts Juniper 4:18 p.m. Jan. 13, 2014 - Sue Chang
Merck shares hit 52-week high on drug hopes, plans for cutbacks 12:31 p.m. Jan. 13, 2014 - Russ Britt
Intercept, Lululemon, SodaStream shares slump 10:22 a.m. Jan. 13, 2014 - Saumya Vaishampayan
S&P 500 gains for week; builder stocks rally as yields fall; the wonder of liver-drug stocks (live blog recap) 10:15 a.m. Jan. 13, 2014 - blogs.marketwatch.com
Clovis Oncology, seen as 'next ICPT,' jumps 5% 9:47 a.m. Jan. 13, 2014 - Victor Reklaitis
Intercept shares trip short-sale circuit breaker 9:32 a.m. Jan. 13, 2014 - Laura Mandaro
Intercept, Celgene on move amid J.P. Morgan event 9:20 a.m. Jan. 13, 2014 - Victor Reklaitis
Biotech Stock Mailbag: Spectrum, Intercept, Orexigen, Amarin, MannKind 6:00 a.m. Nov. 14, 2014 - TheStreet.com
Intercept Pharmaceuticals Slumps: ICPT Falls 5.9% in Session - Tale of the Tape 8:34 a.m. Nov. 13, 2014 - Zacks.com
Intercept Pharmaceuticals (ICPT) Is Weak On High Volume Today 10:00 a.m. Nov. 12, 2014 - TheStreet.com
Intercept Pharmaceuticals (ICPT) Downgraded From Hold to Sell 9:21 a.m. Nov. 12, 2014 - TheStreet.com
Intercept Pharmaceuticals' (ICPT) AASLD Investor Event - Transcript 1:54 p.m. Nov. 11, 2014 - Seeking Alpha
Conatus Pharmaceuticals (CNAT): Will Loss Narrow in Q3? - Analyst Blog 1:50 p.m. Nov. 11, 2014 - Zacks.com
Intercept Pharmaceuticals' Shares Crash on FLINT Results - Analyst Blog 5:03 p.m. Nov. 10, 2014 - Zacks.com
Intercept Seen as Poster-boy for Possible Biotech Bubble 2:58 p.m. Nov. 10, 2014 - TheStreet.com
Biotech Weekly: When Mid Caps Are Priced Nearly For Perfection 10:28 a.m. Nov. 10, 2014 - Seeking Alpha
Intercept Pharmaceuticals (ICPT) Marked As A Dead Cat Bounce Stock 9:48 a.m. Nov. 10, 2014 - TheStreet.com
Stock Movers: Why Medicals Issues Are Dipping Today 2:26 p.m. Nov. 7, 2014 - Investors Business Daily
Intercept Pharmaceuticals (ICPT) Trading With Heavy Volume Before Market Open 8:34 a.m. Nov. 7, 2014 - TheStreet.com
10-Q: INTERCEPT PHARMACEUTICALS INC 5:24 p.m. Nov. 6, 2014 - Edgar Online - (EDG = 10Q, 10K)
Will Intercept Pharmaceuticals' (ICPT) Q3 Loss Narrow? - Analyst Blog 4:02 p.m. Nov. 6, 2014 - Zacks.com
Meet The 5 Companies Loving Obamacare 7:04 p.m. Nov. 4, 2014 - Benzinga.com
The Time Is Now For Northwest Biotherapeutics 3:16 p.m. Oct. 29, 2014 - Seeking Alpha
3 Hot Ways to Play the Biotechnology Bonanza 6:36 a.m. Sept. 16, 2014 - InvestorPlace.com
Biotech Stocks With Upside Target Ebola, Liver Disease 6:30 a.m. Sept. 16, 2014 - InvestorPlace.com
Is Intercept Pharmaceuticals Building The Next Great Specialty Franchise? 2:30 p.m. Sept. 15, 2014 - Seeking Alpha
Biotechs With Upside Target Ebola And Liver Disease: MLV's Vernon Bernardino 9:16 a.m. Sept. 11, 2014 - Seeking Alpha
Intercept Announces Additional Data for OCA in Primary Biliary Cirrhosis 8:02 a.m. Nov. 8, 2014 - GlobeNewswire
FLINT Trial in NASH Published in The Lancet 7:06 p.m. Nov. 6, 2014 - GlobeNewswire
Intercept to Report Third Quarter 2014 Results on November 7 and Present at Upcoming Conferences 5:02 a.m. Oct. 31, 2014 - GlobeNewswire
Recognition, Product Enhancement, Marketing Approval, Upcoming Events, and Quarterly Earnings - Research Reports on Abbott, Illumina, Thermo Fisher, Intercept and Stryker 7:40 a.m. Oct. 22, 2014 - PR Newswire - PRF
Critical Alerts For Exxon Mobil, Celgene, Verizon, Intercept Pharmaceuticals and Lockheed Martin Released By InvestorsObserver 8:31 a.m. Oct. 8, 2014 - PR Newswire - PRF
Intercept Announces Data to be Presented at the 2014 AASLD Annual Meeting 5:30 a.m. Oct. 8, 2014 - GlobeNewswire
Quarterly Changes to the NASDAQ Q-50 Index 6:06 a.m. Sept. 15, 2014 - GlobeNewswire
Intercept Pharmaceuticals Recognizes International PBC Day 5:56 a.m. Sept. 12, 2014 - GlobeNewswire
Critical Alerts For Apple, Kinder Morgan, Stratasys, Intercept Pharmaceuticals and NPS Pharmaceuticals Released By InvestorsObserver 8:31 a.m. Sept. 8, 2014 - PR Newswire - PRF
Intercept to Present at Upcoming Investor Conferences 7:05 a.m. Aug. 26, 2014 - GlobeNewswire
Drug Approvals, Financial Results, Market Activity, New Mobile Applications, and Company Updates - Research Reports on Intercept, Exact Sciences, Thermo Fisher Scientific, Illumina and Agilent 8:00 a.m. Aug. 15, 2014 - PR Newswire - PRF
Critical Alerts For GoPro, Intercept Pharmaceuticals, Pixelworks, Vertex Pharmaceuticals and General Mills. Released By InvestorsObserver 8:31 a.m. Aug. 13, 2014 - PR Newswire - PRF
Intercept to Host Second Quarter 2014 Update on August 11 and Present at Upcoming Investor Conference 4:01 p.m. Aug. 4, 2014 - GlobeNewswire
Galectin, Intercept, Others Vying for Lead Drugs in NASH Epidemic 9:03 a.m. July 24, 2014 - ACCESSWIRE
Intercept Pharmaceuticals Names Lazar Partners Agency of Record 9:08 a.m. July 10, 2014 - Marketwire
Catalysts on the Horizon for Companies Developing NAFLD and NASH Drugs 8:42 a.m. June 26, 2014 - ACCESSWIRE
Conference Presentations, Settlement and License Agreement, New Leadership, and Start of Phase III Study - Analyst Notes on Alexion, Mylan, Novartis, GSK and Intercept 4:50 a.m. June 11, 2014 - PR Newswire - PRF
FDA Approvals, Digital Health Guidance, Conference Presentations, and Recognitions - Analyst Notes on Intercept Pharmaceuticals, Cigna, Baxter, Questcor and Mallinckrodt 6:00 a.m. June 3, 2014 - PR Newswire - PRF
Technical Coverage of Health Care Sector Equities -- Research on Intercept Pharma, ACADIA Pharma, DENTSPLY Intl., and OraSure Technologies 10:42 a.m. May 15, 2014 - PR Newswire - PRF
Wall Street In and Out of Love with NASH Drug Developers 9:21 a.m. May 13, 2014 - ACCESSWIRE
(0)
(0)Scroll down for more posts ▼